ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases
- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL Bio's Grabody-B platform technology to effectively deliver molecules a cross the blood-brain barrier - ABL...
Saramonic K9 Unveiled - Digital UHF Audio System With User Experience Friendlier for Filmmakers
NEW YORK, April 7, 2025 /PRNewswire/ -- Saramonic launches Saramonic K9, its first dual-channel digital UHF wireless audio system for filmmakers during NAB Show 2025. This new system features what a professional looks for in a reliable audio system:...
Agoda Highlights Top Markets Traveling to Thailand for Songkran 2025
SINGAPORE, April 7, 2025 /PRNewswire/ -- Digital travel platform Agoda reveals the top international markets exploring traveling to Thailand for Songkran this year, with Malaysia leading the list. Based on accommodation searches made on Agoda,...
Hurom Wins Patent Infringement Case Against NUC (Kuvings) in European Unified Patent Court
Court Bans NUC Juicer Sales in Europe, Orders Compensation, Recall, and Destruction of Infringing Products SEOUL, South Korea, April 7, 2025 /PRNewswire/ -- Hurom, the global pioneer in slow juicing and the inventor of the world's first vertical...
George Clinical Rebrands as Emerald Clinical Trials
New name reflects company's growth and vision to help bring certainty and transparency to global clinical trials SINGAPORE, April 7, 2025 /PRNewswire/ -- George Clinical, a leading clinical research organization (CRO) operating worldwide, is pleased...
DPC Dash - Domino's Pizza China Shows Growth Momentum, While Building Resilient Community in the First Quarter of 2025
HONG KONG, April 7, 2025 /PRNewswire/ -- DPC Dash – Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), Domino's Pizza's exclusive master franchisee in the China Mainland, the Hong Kong Special Administrative Region of China, and the Macau...
Luye Pharma Announces U.S. Launch of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Schizoaffective Disorder
PRINCETON, N.J., April 7, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI® (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in the U.S. for the treatment of adults with...
Telix Appoints Paul Schaffer as Chief Technology Officer
MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology...